Skip to main content
. 2022 Jan 20;43(34):3198–3208. doi: 10.1093/eurheartj/ehab841

Figure 5.

Figure 5

Newer and emerging lipid-lowering therapies target different aspects of lipid metabolism. The statins target hydroxymethylglutaryl coenzyme A reductase. The newer and emerging agents target other aspects of lipid metabolism as shown here. B48 refers to the shorter form of apolipoprotein B produced by RNA editing in the intestine. B100 refers to the longer form produced in the liver. See the list for explanations of other abbreviations.